Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-001744
Filing Date
2025-03-31
Accepted
2025-03-31 16:17:43
Documents
74
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1779614
2 ex4-3.htm EX-4.3 30061
3 ex19-1.htm EX-19.1 46643
4 ex21-1.htm EX-21.1 5122
5 ex31-1.htm EX-31.1 12374
6 ex31-2.htm EX-31.2 12307
7 ex32-1.htm EX-32.1 6853
8 ex32-2.htm EX-32.2 6640
9 ex99-1.htm EX-99.1 51339
10 aud_001.jpg GRAPHIC 5571
  Complete submission text file 0001641172-25-001744.txt   7022828

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE exoz-20241231.xsd EX-101.SCH 42981
12 XBRL CALCULATION FILE exoz-20241231_cal.xml EX-101.CAL 58902
13 XBRL DEFINITION FILE exoz-20241231_def.xml EX-101.DEF 170713
14 XBRL LABEL FILE exoz-20241231_lab.xml EX-101.LAB 421843
15 XBRL PRESENTATION FILE exoz-20241231_pre.xml EX-101.PRE 325826
76 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 980614
Mailing Address 750 ROYAL OAKS DR MONROVIA CA 91016
Business Address 750 ROYAL OAKS DR MONROVIA CA 91016 (626) - 415 - 1488
EXOZYMES INC. (Filer) CIK: 0002010788 (see all company filings)

EIN.: 834550057 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-42204 | Film No.: 25793510
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)